A Pennsylvania-based pharmaceutical firm and the FDA issued a recall of an injectable blood pressure medicine after a customer noticed "a visible black particulate matter" in a vial. Dr. Bernard Ashby ...
The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to ...
The Trump administration’s food regulatory agenda will come into sharper focus once nominees for the U.S. Department of Health and Human ...
The Trump administration should embrace it as an opening salvo for its “Make America Healthy Again ... including the FDA and the Centers for Disease Control and Prevention, to study better ...